Staphylococcus aureus infection pathophysiology: Difference between revisions
Jump to navigation
Jump to search
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Pathophysiology== | ==Pathophysiology== | ||
Staphylococcus aureus is a highly virulent bacteria that has been recognized as a cause of a wide variety of diseases in humans. Several strains of Staphylococcus aureus bacteria exist. The characteristic attribute of | Staphylococcus aureus is a highly virulent bacteria that has been recognized as a cause of a wide variety of diseases in humans. Several strains of Staphylococcus aureus bacteria exist. The characteristic attribute of a particular strain such as toxins and extracellular factors, invasive properties (such as adherence, biofilm formation, and resistance to phagocytosis), majorly determine the pathogenesis of Staphylococcus aureus infection.<ref name="pmid26142662">{{cite journal| author=Chessa D, Ganau G, Mazzarello V| title=An overview of Staphylococcus epidermidis and Staphylococcus aureus with a focus on developing countries. | journal=J Infect Dev Ctries | year= 2015 | volume= 9 | issue= 6 | pages= 547-50 | pmid=26142662 | doi=10.3855/jidc.6923 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26142662 }} </ref> | ||
==References== | ==References== |
Revision as of 16:55, 8 May 2017
Staphylococcus aureus infection Main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Pathophysiology
Staphylococcus aureus is a highly virulent bacteria that has been recognized as a cause of a wide variety of diseases in humans. Several strains of Staphylococcus aureus bacteria exist. The characteristic attribute of a particular strain such as toxins and extracellular factors, invasive properties (such as adherence, biofilm formation, and resistance to phagocytosis), majorly determine the pathogenesis of Staphylococcus aureus infection.[1]
References
- ↑ Chessa D, Ganau G, Mazzarello V (2015). "An overview of Staphylococcus epidermidis and Staphylococcus aureus with a focus on developing countries". J Infect Dev Ctries. 9 (6): 547–50. doi:10.3855/jidc.6923. PMID 26142662.